Variant · Expression
FGFR3 Expression
CI-VAR-00001062Explore in graph →CIViC 5374
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 36794128
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Lung Non-Small Cell Carcinoma1 | ||||||||
| FGFR3 Expression | (prognostic) | Prognostic | B | Supports Better Outcome | 3 | submitted | EID12736DNA was extracted from the paraffin-embedded tissues of 86 NSCLC tissues. 72 of the samples were tested for FGFR3 alterations in exons 7, 10, and 15 by sequencing, and two showed point mutations causi… (full text at CIViC) PMID 36794128 · Lin et al., 2023 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available